Medical equipments

Tender description

Histocompatibility and Immunogenetics (H&I) is a strategic business function of NHS Blood and Transplant (NHSBT) that provides a portfolio of testing and advice which supports the diagnosis and/ or treatment of a variety of medical conditions in the following clinical areas: — Solid organ transplantation and clinical advice for donor selection; — Haematopoietic stem cell transplantation and clinical advice for donor selection; — Blood transfusion and transfusion reactions (SHOT); — Platelet refractoriness and provision of HLA/ HPA selected components; — Platelet immunology; — Granulocyte immunology; — Immunogenetics including diagnostic testing and pharmacogenetics; — Haematopoietic stem cell donor registry typing. NHSBT require Human leukocyte antigen (HLA) rapid typing system(s) to ensure compatibility between donors and recipients of solid organ transplantation (renal, liver and cardiothoracic). Building on our strengths as a national provider, NHSBT's strategic aim is for its H&I services to become the preferred provider and supplier of choice for H&I related services in NHS England. We will work with the successful suppliers to realise this ambition and to perform HLA rapid typing in an efficient, timely and cost effective manner to meet the demands and expectations of our customers and the patients we serve. The following shows the Framework Agreement ranking. Linkage Biosciences are the primary supplier for NHSBT under this Framework Agreement. 1. Linkage Biosciences, 2. Quest Biomedical, 3. VH Bio.